Predictive value of peripheral blood immune markers for castration-resistant prostate cancer development after endocrine therapy
{{output}}
Objective: To evaluate the predictive value of peripheral blood immune markers for progression to castration-resistant prostate cancer (CRPC) in prostate cancer (PCa) patients undergoing endocrine therapy. ... ...
